As regulators continue to assess the role of nicotine pouches within tobacco control frameworks, evidence on how these products are actually used over time remains limited. A recently published prospective
Across Europe, policymakers continue to express concern that fragmented nicotine regulation is leaving young people exposed to risk. Recent commentary has pointed to uneven national rules governing nicotine pouches, vapes,
A GINN response to “The war on snus” The Cyprus Mail article “The war on snus” highlights a regulatory paradox that is becoming increasingly familiar across Europe: nicotine pouches are
Executive context Innovation in nicotine pouches has largely focused on formulation variables, nicotine strength, pH, buffering systems, flavours, and moisture content. These factors shape nicotine delivery and user perception and
Regulation, clinical context, and evidence-based harm reduction Cigarette smoking continues to impose a disproportionate health burden in Appalachia, a region marked by persistently high smoking prevalence, elevated rates of cardiovascular
A Deep Dive into the Future of Novel NicotineWe wish to share the latest episode of the Tobacco Asia / InterTabac podcast, where GINN’s Director Shem Baldeosingh joins Thomas Schmid
Recent analysis published in The Lancet Public Health reinforces a long-standing but often overlooked reality in tobacco control: nicotine use is not a monolith, and public-health outcomes depend critically on
Nicotine pouch performance is often discussed almost exclusively in terms of formulation. Nicotine concentration, pH, buffering systems, flavour chemistry, and moisture balance dominate both technical development and regulatory review. These
🇨🇳 China Confirms Nicotine Pouches Are Now Under the State Tobacco Monopoly China’s move to classify nicotine pouches within the state tobacco monopoly is now confirmed not only by specialist
Youth “addiction” to nicotine pouches and other smoke-free nicotine products is increasingly invoked as a political shorthand, often without reference to how addiction is actually defined in modern clinical science.
Expectations around the European Union’s next revision of the Tobacco Products Directive (TPD3) have continued to shift, but a clearer picture is now emerging. Based on Commission planning documents, specialised
As nicotine pouches gain visibility in the United States and other markets, debate around their public-health role has intensified. Much of this discussion has been driven by concern over youth